Recreational pot industry preps for New Jersey debut

In the News

Recreational pot industry preps for New Jersey debut

On Wednesday, Feb. 10, 2021, Curaleaf, a leading U.S. provider of consumer products in cannabis, opened Curaleaf Jacksonville San Jose, marking the company’s 100th dispensary nationwide.

Heather AllmanPUBLISHER: CANNABIS LAW REPORT

Can the cannabis industry be an agent of social justice? Or is it just another big business?

Jason White has created dazzling advertising and marketing campaigns for Nike and Disney, the World Cup and Olympic Games, to name a few. But when the Georgetown alumnus told his parents he was exiting Apple-owned Beats by Dre for the cannabis industry, the announcement landed with a thud.

“What they heard was, ‘You’re going to sell weed,’ ” the 44-year-old said, laughing.White is now chief marketing officer at Curaleaf Holdings Inc., which says it is the world’s largest provider (by revenue) of legal medical and recreational cannabis.

While some n legal pot to a gold rush, White — who is African American and Cuban — talks of repairing communities harmed by the war on drugs. “Some are very wary of cannabis, having seen people arrested and their voting rights taken away,” he says.

“But as cannabis has become more mainstream, others don’t see harm, but opportunity. I want to use this platform to help improve society.”

Curaleaf Reports Record Revenues, Names New CEO

Curaleaf reported record financial and operational results for the third quarter of the year with pro forma revenue of $215.3 million, and year-to-date managed revenue of $419.6 million, including third-quarter revenues of $193.2 million – a 164 percent increase.

The firm indicated an approximately $46,934,000 gross profit increase from cannabis sales from $42,735,000 in Q2 to $89,669,000 in the third quarter. The company also reported a 51 percent increase in adjusted EBITDA from $27,994,000 to $42,295,000 – representing a 305 percent year-over-year increase.

Curaleaf Announces Participation at the Virtual Canaccord Genuity 40th Annual Growth Conference

WAKEFIELD, Mass., Aug. 12, 2020 /PRNewswire/ — Curaleaf Holdings, Inc.

(CSE: CURA /OTCQX: CURLF), the leading vertically integrated multi-state cannabis operator in the United States, today announced that Boris Jordan, Curaleaf Executive Chairman of the Board, will participate in a Curaleaf Fireside Chat at the Virtual Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13th at 10:00 a.m. ET. Additionally, Curaleaf management will be hosting virtual one-on-one meetings with investors in connection with the conference.

Curaleaf wants to be the Starbucks of weed

Curaleaf, the US's biggest cannabis company, with a market capitalization of about $3.2 billion, just keeps getting bigger.

The Wakefield, Massachusetts-based operator of grow houses, dispensaries, and brands turning out tinctures, vapes, edibles, topicals, and flower (as the industry refers to dried cannabis) has been steadily acquiring other cannabis companies in an effort to become, as CEO Joe Lusardi puts it, “the first true national cannabis brand with the widest distribution in the country.”

Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

Curaleaf Holdings (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. Due to the brand’s high quality and best product experience, it received positive feedback in medical and adult-use markets.

Currently, Curaleaf has introduced the brand in nine states including Oregon, California, Nevada, Arizona, Colorado, Michigan, Maryland, Oklahoma, and Connecticut.

On Tuesday, the company announced its plans to expand the brand to other states including Maine, Massachusetts, Ohio, and Florida by August.

Miami's First Drive-Thru Marijuana Dispensary Opens Today

In Miami, you can find drive-thrus for croquetas, flan, tres leches, and even vaca frita. Beginning today, you can also pick up pot — provided you have a medical marijuana card.

Curaleaf, one of the largest cannabis brands in the nation, is opening a drive-thru dispensary at 5400 NW 72nd Ave., just outside Doral. The 4,000-square-foot storefront includes private consultation rooms and sells a variety of medical marijuana products, including smokable weed, now that it's legal in Florida.

Pot dispensary launches in Newburgh

The first medical marijuana dispensary in Orange County opened last week.Curaleaf New York opened a medical dispensary in Newburgh, at 8 North Plank Rd., on Friday, said Michelle Bodner, CEO of Curaleaf.

The dispensary is the second to open in the mid-Hudson Valley, after Etain Health Medical Marijuana Dispensary in Kingston, and the first for PalliaTech, the Massachusetts-based parent company of Curaleaf. No dispensaries are open in Dutchess County.

Curaleaf will provide patients access to medical-grade cannabis in a variety of forms, including capsules, tablets, oils and under-the-tongue strips, according to Bodner.

Источник: https://curaleaf.com/in-the-news

Open A Dispensary In New Jersey- Dispensary Permit Consulting

Recreational pot industry preps for New Jersey debut

Status: In New Jersey, individuals 21+ may possess and use marijuana, and registered patients may possess and use medical marijuana. State licensed businesses may grow, process, transport, and dispense marijuana.

CBD ProgramMedical ProgramRecreational ProgramAre Applications Open?
LegalLegalNot legalclosed

Work with the Industry Experts

Enter an emerging $14B market with a 10+ year industry veteran riding shotgun as your franchise partner.

__________

Work with Us

Education = Success

New Jersey just legalized recreational cannabis. Learn what is typically involved in the application process for a cannabis business license.

__________

Learn Now

DIY with Confidence

Educate yourself on how to run a dispensary, processing, or cultivation facility with our business plan templates.

__________

View Plans

Let Us Know How You'd to Get Involved in the Industry

DispensariesCultivationManufacturing/ProcessingTransportation
0000

The cannabis legalization bill, A21, outlines the following license types:

Class 1 Cannabis Grower License – grows, cultivates, or produces cannabis in this State, and sells, and may transport, this cannabis to other cannabis growers, cannabis processors, cannabis wholesalers, or cannabis retailers, but not to consumers. A cannabis grower may also be referred to as a “cannabis cultivation facility.”

Class 2 Cannabis Processor License – processes cannabis items in this State by purchasing or otherwise obtaining cannabis, manufacturing, preparing, and packaging cannabis items, and selling, and optionally transporting, these items to other cannabis processors, cannabis wholesalers, or cannabis retailers, but not to consumers. A cannabis processor may also be referred to as a “cannabis product manufacturing facility.”

Class 3 Cannabis Wholesaler License – purchases or otherwise obtains, stores, sells or otherwise transfers, and may transport, cannabis items for the purpose of resale or other transfer to either to another cannabis wholesaler or to a cannabis retailer, but not to consumers.

Class 4 Cannabis Distributor License – transports cannabis items in bulk intrastate, from one licensed cannabis establishment to another licensed cannabis establishment and may engage in the temporary storage of cannabis items as necessary to carry out transportation activities.

Class 5 Cannabis Retailer License – purchases or otherwise obtains cannabis from cannabis growers and cannabis items from cannabis processors or cannabis wholesalers, and sells these to consumers from a retail store, and may use a cannabis delivery service or a certified cannabis handler for the off-premises delivery of cannabis items and related supplies to consumers.

Class 6 Cannabis Delivery License – provides courier services for a cannabis retailer in order to make deliveries of cannabis items and related supplies to a consumer.

As of February 22, 2021, the Cannabis Regulatory Commission has 180 days (six months) to develop specific business regulations, including application and licensing fees.

Then, the commission shall begin accepting and processing business license applications within 30 days after the commission’s initial rules and regulations have been adopted.

We anticipate the commission to create their own website where application and licensing information will be posted.

As the program was established in 2010, a vertically-integrated Alternative Treatment Center license authorized a licensee to cultivate, process, and dispense medical marijuana for registered patients. The state awarded six ATCs in 2011, and an additional six ATCs in 2018.

With the submission of an executive order from Governor Phil Murphy in May 2019, Alternative Treatment Center (ATC) licenses may now have specialty endorsements for cultivation, processing, or dispensing. 

ATC, Cultivation Endorsement – a permit endorsement that allows an ATC to possess, cultivate, plant, grow, harvest, and package usable marijuana (including in pre-rolled forms); and display, transfer, transport, distribute, supply, or sell marijuana to other ATCs, but not directly to registered qualifying patients.

    • Cultivation endorsements are tiered by canopy size to allow for small, medium, and large business participation. the Department will seek to issue cultivation endorsements in the following tiers of canopy size:
      • 20,001 square feet to 30,000 square feet: up to 2 cultivation endorsements
      • 5,001 square feet to 20,000 square feet: up to 2 cultivation endorsements
      • Up to 5,000 square feet: up to 1 cultivation endorsement.

Application Fees: All applications require a $20,000 application fee in the form of two payments, one $18,000 check and one $2,000 check. If an application is unsuccessful, the Department will keep the $2,000 check and destroy the $18,000 check.

Applications were due August 22, 2019, and the Department is not seeking additional cultivation endorsements at this time.

As the program was established in 2010, a vertically-integrated Alternative Treatment Center license authorized a licensee to cultivate, process, and dispense medical marijuana for registered patients. The state awarded six ATCs in 2011, and an additional six ATCs in 2018.

With the submission of an executive order from Governor Phil Murphy in May 2019, Alternative Treatment Center (ATC) licenses may now have specialty endorsements for cultivation, processing, or dispensing. 

ATC, Manufacturing Endorsement – a permit endorsement that allows an ATC to possess and process usable marijuana; purchase usable marijuana from other ATCs possessing a cultivating endorsement; manufacture products containing marijuana approved by the Department; conduct research and develop products containing marijuana for approval by the Department; and to display, transfer, transport, distribute, supply, or sell marijuana and products containing marijuana to other ATCs, but not directly to registered qualifying patients.

The Department is not seeking manufacturing endorsements at this time.

As the program was established in 2010, a vertically-integrated Alternative Treatment Center license authorized a licensee to cultivate, process, and dispense medical marijuana for registered patients. The state awarded six ATCs in 2011, and an additional six ATCs in 2018.

With the submission of an executive order from Governor Phil Murphy in May 2019, Alternative Treatment Center (ATC) licenses may now have specialty endorsements for cultivation, processing, or dispensing. 

ATC, Dispensary Endorsement – a permit endorsement that allows an ATC to purchase usable marijuana and products containing marijuana from other ATCs authorized to cultivate or manufacture usable marijuana or products containing marijuana; and possess, display, supply, sell, and dispense, usable marijuana and/or products containing marijuana, to registered qualifying patients.

Application Fees: All applications require a $20,000 application fee in the form of two payments, one $18,000 check and one $2,000 check. If an application is unsuccessful, the Department will keep the $2,000 check and destroy the $18,000 check.

Applications are due August 21, 2019, and the Department is not seeking additional dispensary endorsements at this time.

Recreational Marijuana Overview:
On December 16, 2019, the New Jersey Assembly and Senate committees passed a resolution approving the question of recreational marijuana legalization to be put before voters on the November 2020 ballot.

The ballot measure would add an amendment to the state constitution that legalizes the recreational use of marijuana for persons age 21 and older and legalizes the cultivation, processing, and sale of retail marijuana. The constitutional amendment would take effect on January 1, 2021.

A new five-member Cannabis Regulatory Commission (CRC) would be responsible for regulating the cultivation, processing, and sale of recreational marijuana. The ballot measure would apply the state sales tax (6.

625 percent) to recreational marijuana but prohibit additional state sales taxes.

The state legislature would be authorized to allow local governments to enact an additional 2 percent sales tax on recreational marijuana.

As expected, on November 3, 2020, New Jersey voters successfully passed the resolution to legalize adult-use of marijuana in the state. The question passed with 67% of voters in favor of legalization, a turnout that was almost exactly predicted by polls leading up to election day. 

On February 22, 2021, Gov. Phil Murphy signed cannabis legalization and decriminalization bills into law to set the implementation of the state’s adult-use program into motion.

Later that week, Murphy appointed the last two members needed to complete the new Cannabis Regulatory Commission responsible for drafting specific regulations, licensing businesses, and overseeing the program.

The Cannabis Regulatory Commission now has 180 days (six months) to develop regulations.

Regulating Departments: Cannabis Regulatory Commission 

Medical Marijuana Overview: 
In 2010, New Jersey legalized medical marijuana use for registered patients suffering from qualifying medical conditions. Patients obtain medical marijuana from an Alternative Treatment Center (ATC). The state awarded six ATCs in 2011, and an additional six ATCs in 2018.

On March 27, 2018, Gov. Phil Murphy made the following immediate changes to New Jersey’s current Medical Marijuana program:

    • Anxiety, migraines, Tourette’s syndrome, chronic pain related to musculoskeletal disorders and chronic visceral pain were added as qualifying conditions
    • The patient fee was reduced 50%
    • The existing 5 medical marijuana treatment centers may open satellite locations
    • Murphy said to address supply, he’s proposing changing regulations to let treatment centers specialize in specific areas, cultivating, dispensing or manufacturing
    • Murphy stated he views the state’s medical marijuana program strictly as a health issue, and he is still pushing for recreational legalization

Governor Phil Murphy then gave the state Legislature until the end of May 2019 to pass a pair of linked bills (SB 10 and SB 2703) to legalize recreational marijuana as well as expand the state’s current medical marijuana program. Otherwise, he said he’ll have no choice but to expand the medical marijuana program on his own to reach more patients.

Governor Murphy kept his word and submitted an executive order in May 2019 to amend the state’s medical marijuana program rules in order to increase medical marijuana entrepreneurial opportunities, product supply, and patient access.

The rule changes include establishing separate specialty permits for cultivators, processors, and dispensaries as well as streamlining the process to add qualifying medical conditions to the program. The rule removes the requirement that the petitions for new qualifying conditions must first go to the Medicinal Marijuana Review Panel.

State regulators also codified some changes already in effect, including qualifying medical conditions that were previously added by Murphy’s administration.

Additionally, Murphy signed the Jake Honig Compassionate Use Medical Marijuana Act into law, which would also make various changes to the state’s current program and present new business opportunities. This bill will make the following changes:

    • Remove the requirement for patients to have a bona fide relationship with their doctor, which usually means one year of appointments, before their doctor is able to recommend medical marijuana as a treatment for them. With the removal of this requirement, the process for recommending patients will become much quicker and more simplified.
    • Establish a new Cannabis Regulatory Commission to regulate the program
    • Legalize home delivery of medical marijuana to registered patients
    • Allow dispensaries to establish “consumption areas” on premises.
    • Call for the licensing of 11 new cultivation centers to meet the growing patient demand

On July 1, 2019, the Department of Health released an updated Request for Applications for 24 additional ATCs. Applications were due August 21, 2019 for dispensary endorsements, and August 22, 2019 for cultivation endorsements and vertically integrated permits.

The ATCs will have three endorsement/permit types: cultivation, dispensing, and vertically integrated permits. Vertically integrated permits include 1 cultivation endorsement, 1 manufacturing endorsement and 1 dispensary endorsement.

In total, the Department will issue up to 5 cultivation endorsements, up to 15 dispensary endorsements, and up to 4 vertically integrated permits.

Read the full Medical Marijuana Act: http://www.njleg.state.nj.us/2008/Bills/PL09/307_.HTM

Qualifying Medical Conditions: Seizure disorder, including epilepsy; intractable skeletal muscular spasticity; or glaucoma; if severe or chronic pain, severe nausea or vomiting, cachexia, or wasting syndrome results from the condition or treatment thereof: positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or cancer; amyotrophic lateral sclerosis, multiple sclerosis, terminal cancer, muscular dystrophy, or inflammatory bowel disease, including Crohn’s disease; terminal illness, if the physician has determined a prognosis of less than 12 months of life; Post-Traumatic Stress Disorder; anxiety; migraines; Tourette’s syndrome; chronic pain related to musculoskeletal disorders and chronic visceral pain; Opioid Use Disorder

Источник: https://dispensarypermits.com/united-states-marijuana-dispensary-laws/open-a-dispensary-in-new-jersey/

NEWS
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: